Gaviscon Double Action Liquid

Gaviscon Double Action Liquid is a liquid oral suspension classified as a alginate-antacid combination. Its formulation contains Sodium alginate, sodium bicarbonate and calcium carbonate, with the exact strength or quantitative composition to be confirmed from the current product packaging where the batch information does not provide a verified value. The dosage form is designed for the route stated on the label, and the physical characteristics of the product determine how it is prepared, applied or taken. Customers should check the pack before use so that the correct strength, formulation and instructions are matched to the product in hand.

The formulation has a defined pharmaceutical or physical profile rather than being interchangeable with other products that may have a similar brand or general category. Sodium alginate reacts with gastric contents to form a floating raft-like layer over the stomach contents. Sodium bicarbonate and calcium carbonate neutralise gastric acid and contribute to the formation of the alginate raft. The physical barrier and acid-neutralising actions occur locally in the upper gastrointestinal tract. Product handling also matters: application technique, measuring accuracy, contact time and storage conditions can affect appropriate use. Keep the original packaging available so the batch, expiry information and current manufacturer instructions can be checked whenever necessary.

Shake the bottle thoroughly before each dose. Measure the required volume with the supplied measure rather than a household spoon. Take after meals and at bedtime if directed, and keep any recommended separation from other oral medicines.

Keep the bottle tightly closed and store according to the temperature stated on the pack. Do not use the liquid after the labelled expiry date or if its appearance has changed unexpectedly.

• Common: Mild local irritation, redness, itching or transient sensitivity may occur, particularly with topical preparations.
• Common: Mild transient discomfort at the application site or sensitivity can occur depending on the formulation.
• Serious: Stop use and seek urgent medical attention for facial or throat swelling, difficulty breathing, widespread blistering rash, severe dizziness or other signs of a serious allergic reaction.

• Known allergy or hypersensitivity to any ingredient in the product.
• Any condition specifically listed as a contraindication on the current package or approved product information.

• Tell a pharmacist about prescription medicines, anticoagulants, antiplatelet medicines and regular supplements before repeated use.
• Avoid combining products with the same active ingredient unless a healthcare professional has checked the total exposure.
• No specific food interaction is established from the supplied product data; follow the current label for any product-specific restriction.

• Read the current label before the first use and check the strength or formulation.
• Use the measuring device supplied with liquid medicines instead of a household spoon.
• Wash hands before and after topical application unless the hands are the treated area.
• Keep the original packaging so expiry, batch and ingredient information remain available.
• Do not share medicines, applicators or single-use topical products with another person.
• Ask a pharmacist if you are pregnant, breastfeeding, caring for a child, taking regular medicines or unsure about the correct dose.

Precautions: People on sodium-restricted diets, with significant kidney disease, recurrent calcium-containing kidney stones or other conditions affected by electrolyte intake should ask a pharmacist or doctor before use. Persistent swallowing difficulty, unexplained weight loss, vomiting blood or black stools requires medical assessment.

When to See a Doctor or Pharmacist: Seek medical or dental assessment for severe, persistent, rapidly worsening or unexplained symptoms, or whenever the product is not producing the expected response within the labelled period.